Volume 9, Issue 4 (6-2024)
SJNMP 2024, 9(4): 393-403 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sheikhzakaryaee N, Zakaryaee S, Rasouli M A, Nemati M. Investigating the cognitive function of breast cancer patients receiving adjunctive chemotherapy. SJNMP 2024; 9 (4) :393-403
URL: http://sjnmp.muk.ac.ir/article-1-599-en.html
URL: http://sjnmp.muk.ac.ir/article-1-599-en.html
1- Department of Nursing, Faculty of Nursing and Midwifery, Kurdistan University of Medical Sciences, Sanandaj, Iran
2- , Department of Midwifery, Faculty of Nursing and Midwifery, Kurdistan University of Medical Sciences, Sanandaj, Iran
3- Faculty of Medicine, Department of Epidemiology and Biostatics, , Kurdistan University of Medical Sciences, Sanandaj, Iran & Faculty of Medicine, Department of Epidemiology and Biostatics, , Kurdistan University of Medical Sciences, Sanandaj, Iran.
4- Department of Midwifery, Faculty of Nursing and Midwifery, Kurdistan University of Medical Sciences, Sanandaj, Iran ,M.O.Nemati2916@gmail.com
2- , Department of Midwifery, Faculty of Nursing and Midwifery, Kurdistan University of Medical Sciences, Sanandaj, Iran
3- Faculty of Medicine, Department of Epidemiology and Biostatics, , Kurdistan University of Medical Sciences, Sanandaj, Iran & Faculty of Medicine, Department of Epidemiology and Biostatics, , Kurdistan University of Medical Sciences, Sanandaj, Iran.
4- Department of Midwifery, Faculty of Nursing and Midwifery, Kurdistan University of Medical Sciences, Sanandaj, Iran ,
Abstract: (1262 Views)
Background & Aim: Up to 60% of breast cancer patients treated with chemotherapy is confronted with cognitive problems, which can have a significant impact on daily activities and quality of life. Therefore, the purpose of the study was to “determine the cognitive function of breast cancer patients receiving adjuvant chemotherapy.
Materials & Methods: In this cross-sectional study, the research population was cancer patients referred to the oncology department of Taw Heed Hospital in Sanandaj. All patients were included in the study by census method. The data collection tool in this study was the form of demographic characteristics and cognitive function assessment of cancer patients FACT-cog. To analyze the research data, version 14 of STATA software and descriptive statistics and analytical statistics including independent chi-square t test were used. A significance level of less than 0.05 was considered.
Results: In this study, 101 breast cancer patients of Taw Heed Hospital, all of whom were women, were included in the study. Their average age was 44.06 ± 15.15 years. The average duration of disease of the participants was 18.7±23.61 months. The results of the study showed that the average cognitive performance score was (68.32±24.15), which is lower than the average score and in the average range.
Conclusions: The results of this study showed that in people with breast cancer who are undergoing chemotherapy, the cognitive function is at an average level, and the necessary training should be done to improve the cognitive function of these patients.
Materials & Methods: In this cross-sectional study, the research population was cancer patients referred to the oncology department of Taw Heed Hospital in Sanandaj. All patients were included in the study by census method. The data collection tool in this study was the form of demographic characteristics and cognitive function assessment of cancer patients FACT-cog. To analyze the research data, version 14 of STATA software and descriptive statistics and analytical statistics including independent chi-square t test were used. A significance level of less than 0.05 was considered.
Results: In this study, 101 breast cancer patients of Taw Heed Hospital, all of whom were women, were included in the study. Their average age was 44.06 ± 15.15 years. The average duration of disease of the participants was 18.7±23.61 months. The results of the study showed that the average cognitive performance score was (68.32±24.15), which is lower than the average score and in the average range.
Conclusions: The results of this study showed that in people with breast cancer who are undergoing chemotherapy, the cognitive function is at an average level, and the necessary training should be done to improve the cognitive function of these patients.
Type of Study: Research |
Subject:
Special
Received: 2024/03/2 | Revised: 2024/07/3 | Accepted: 2024/06/26 | Published: 2024/06/26 | ePublished: 2024/06/26
Received: 2024/03/2 | Revised: 2024/07/3 | Accepted: 2024/06/26 | Published: 2024/06/26 | ePublished: 2024/06/26
References
1. Bidhendi-Yarandi R, Panahi MH. Trends in Leading Cancer Incidence among Iranian Women: Annual Cancer Registry Reports, 2003-2015. Iranian Journal of Public Health. 2021;50(8):1705. [Persian] [DOI:10.18502/ijph.v50i8.6818]
2. Asadi S. Epidemiologic transition in Iran with emphasis on the third stage of transition. Journal of Community Health Research. 2017;6(4):248-57. [Persian]
3. Organization. WHO. breast cancer. overtakes lung cancer in terms of number of newcancer cases worldwide [EB/OL]. 2021.
4. Kazeminia M, Salari N, Hosseinian-Far A, Akbari H, Bazrafshan M-R, Mohammadi M. The prevalence of breast cancer in Iranian women: a systematic review and meta-analysis. Indian Journal of Gynecologic Oncology. 2022;20(1):14. [DOI:10.1007/s40944-022-00613-4]
5. Cheng H, Sit JW, So WK. The symptom burden in breast cancer survivors. Current breast cancer reports. 2016;8:40-6. [DOI:10.1007/s12609-016-0201-z]
6. Downie FP, Mar Fan HG, Houédé‐Tchen N, Yi Q, Tannock IF. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment. Psycho‐Oncology: Journal of the Psychological, Social and Behavioral Dimensions of Cancer. 2006;15(10):921-30. [DOI:10.1002/pon.1035]
7. Cifu G, Power MC, Shomstein S, Arem H. Mindfulness-based interventions and cognitive function among breast cancer survivors: a systematic review. BMC cancer. 2018;18(1):1-13. [DOI:10.1186/s12885-018-5065-3]
8. Bouchardy C, Rapiti E, Benhamou S. Cancer registries can provide evidence-based data to improve quality of care and prevent cancer deaths. Ecancermedicalscience. 2014;8:1-8.
9. Mathers CD, Lopez AD, Murray CJ. The burden of disease and mortality by condition: data, methods, and results for 2001. Global burden of disease and risk factors. 2006;45(88):10.1596.
10. Wefel JS, Kesler SR, Noll KR, Schagen SB. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults. CA: a cancer journal for clinicians. 2015;65(2):123-38. [DOI:10.3322/caac.21258]
11. Coelho-Junior H, Marzetti E, Calvani R, Picca A, Arai H, Uchida M. Resistance training improves cognitive function in older adults with different cognitive status: a systematic review and Meta-analysis. Aging & mental health. 2022;26(2):213-24. [DOI:10.1080/13607863.2020.1857691]
12. Glisky EL. Changes in cognitive function in human aging. Brain aging. 2007:3-20. [DOI:10.1201/9781420005523-1]
13. Jim HS, Phillips KM, Chait S, Faul LA, Popa MA, Lee Y-H, et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. Journal of Clinical Oncology. 2012;30(29):3578. [DOI:10.1200/JCO.2011.39.5640]
14. Koppelmans V, Breteler M, Boogerd W, Seynaeve C, Gundy C, Schagen S. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Journal of Clinical Oncology. 2012;30(10):1080-6. [DOI:10.1200/JCO.2011.37.0189]
15. Wei X, Yuan R, Yang J, Zheng W, Jin Y, Wang M, et al. Effects of Baduanjin exercise on cognitive function and cancer-related symptoms in women with breast cancer receiving chemotherapy: a randomized controlled trial. Supportive Care in Cancer. 2022:1-13. [DOI:10.21203/rs.3.rs-1044265/v1]
16. Joly F, Giffard B, Rigal O, De Ruiter MB, Small BJ, Dubois M, et al. Impact of cancer and its treatments on cognitive function: advances in research from the Paris International Cognition and Cancer Task Force Symposium and update since 2012. Journal of pain and symptom management. 2015;50(6):830-41. [DOI:10.1016/j.jpainsymman.2015.06.019]
17. Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. International review of psychiatry. 2014;26(1):102-13. [DOI:10.3109/09540261.2013.864260]
18. Conroy SK, McDonald BC, Smith DJ, Moser LR, West JD, Kamendulis LM, et al. Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast cancer research and treatment. 2013;137(2):493-502. [DOI:10.1007/s10549-012-2385-x]
19. Kumar A, Foster TC. Neurophysiology of old neurons and synapses. Brain aging. 2007:229-50. [DOI:10.1201/9781420005523-10]
20. Hess LM, Huang HQ, Hanlon AL, Robinson WR, Johnson R, Chambers SK, et al. Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: an NRG oncology/gynecologic oncology group study. Gynecologic oncology. 2015;139(3):541-5. [DOI:10.1016/j.ygyno.2015.10.003]
21. Amidi A, Hosseini S, Leemans A, Kesler SR, Agerbæk M, Wu LM, et al. Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy. JNCI: Journal of the National Cancer Institute. 2017;109(12). [DOI:10.1093/jnci/djx085]
22. Magnuson A, Ahles T, Chen BT, Mandelblatt J, Janelsins MC. Cognitive function in older adults with cancer: assessment, management, and research opportunities. Journal of Clinical Oncology. 2021;39(19):2138. [DOI:10.1200/JCO.21.00239]
23. Pato M MA, Allahyari A, Payandeh M. Studying the factor analysis and psychometric properties of the Functional Assessment of Cancer Therapy - breast (FACT-B) Scale version 4 in women with breast cancer. Health Psychology 2016;15(17):99-114. [Persian]
24. Koevoets E, Schagen S, De Ruiter M, Geerlings M, Witlox L, Van der Wall E, et al. Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study). Breast cancer research. 2022;24(1):36. [DOI:10.1186/s13058-022-01530-2]
25. Von Ah D, Tallman EF. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument. Journal of pain and symptom management. 2015;49(4):697-706. [DOI:10.1016/j.jpainsymman.2014.08.012]
26. LoBiondo-Wood G, Brown CG, Knobf M, Lyon D, Mallory G, Mitchell SA, et al., editors. Priorities for oncology nursing research: the 2013 national survey. Oncology Nursing Forum; 2014. [DOI:10.1188/14.ONF.67-76]
27. Zeng Y, Cheng AS, Song T, Sheng X, Zhang Y, Liu X, et al. Subjective cognitive impairment and brain structural networks in Chinese gynaecological cancer survivors compared with age-matched controls: a cross-sectional study. BMC cancer. 2017;17(1):1-10. [DOI:10.1186/s12885-017-3793-4]
28. Bray VJ, Dhillon HM, Vardy JL. Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. Journal of Cancer Survivorship. 2018;12:537-59. [DOI:10.1007/s11764-018-0692-x]
29. Debess J, Riis J, Engebjerg MC, Ewertz M. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast cancer research and treatment. 2010;121:91-100. [DOI:10.1007/s10549-010-0756-8]
30. Palmer JL, Trotter T, Joy AA, Carlson LE. Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls. Journal of Cancer Survivorship. 2008;2:275-82. [DOI:10.1007/s11764-008-0070-1]
31. Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliative & supportive care. 2007;5(3):273-80. [DOI:10.1017/S1478951507000442]
32. Van Dyk K, Bower JE, Crespi CM, Petersen L, Ganz PA. Cognitive function following breast cancer treatment and associations with concurrent symptoms. Npj breast cancer. 2018;4(1):25. [DOI:10.1038/s41523-018-0076-4]
33. Hartman SJ, Marinac CR, Natarajan L, Patterson RE. Lifestyle factors associated with cognitive functioning in breast cancer survivors. Psycho‐Oncology. 2015;24(6):669-75. [DOI:10.1002/pon.3626]
34. Vance V, Mourtzakis M, McCargar L, Hanning R. Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obesity reviews. 2011;12(4):282-94. [DOI:10.1111/j.1467-789X.2010.00805.x]
35. Alfano CM, Lichstein KL, Vander Wal GS, Smith AW, Reeve BB, McTiernan A, et al. Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life. Breast cancer research and treatment. 2011;130:243-54. [DOI:10.1007/s10549-011-1530-2]
36. Carroll JE, Van Dyk K, Bower JE, Scuric Z, Petersen L, Schiestl R, et al. Cognitive performance in survivors of breast cancer and markers of biological aging. Cancer. 2019;125(2):298-306. [DOI:10.1002/cncr.31777]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
